top of page
AI & Technology
Artificial intelligence is reshaping every industry — but most investors only see the surface. This category analyzes AI from the infrastructure up: the computing systems, energy demands, semiconductor supply chains, and technology trends driving returns. From data centers to investment thesis, science and technology first. Financial insight second.
Fame, Narratives, and the Investor Opportunity Hidden in Plain Sight
Nvidia lost $589 billion in a single session on the DeepSeek news — the largest one-day market cap loss in history — then recovered 9% the next day. The narrative never broke; only the price moved. A framework for reading fame-driven dips in Apple, Tesla, Nvidia, and Meta as opportunities, not warnings.
May 28
U.S.–China Technology Sector Analysis
Washington quietly cleared Nvidia's H200 AI chips for sale to Alibaba, Tencent, and ByteDance — announced through regulatory action, not summit fanfare. Six tech CEOs came to Beijing not chasing new opportunity, but defending dependencies years and billions in the making.
May 17
AI Will Win: How To Build It To Last
Most AI inference runs through three cloud providers and one or two chip manufacturers — a single point of failure smaller than a mid-sized corporate IT department, for the entire global AI stack. Why AI dominance is no longer the real question, and what building resilience around it actually requires.
May 8
Can We Go Back? Why pre-AI normal is already gone for some industries
A hospital running AI-assisted radiology for a decade doesn't have the radiologists to revert — they were never hired, never trained. Why the fallback to pre-AI operation isn't a step backward in time for the most dependent industries. It's a step off a cliff.
May 8
What Breaks When AI Goes Dark: Industries on the Edge of AI Dependency — and What Happens When the Infrastructure Fails
AI has quietly become the third layer of critical infrastructure, after power and internet — but unlike those systems, it has no equivalent resilience standards, regulatory oversight, or stress-testing. A sector-by-sector risk map of what breaks first, and why the fallback keeps disappearing.
May 8
Tech vs. Pharma: Why Technology Leads S&P 500 Growth — And What It Means for Investors
A tech company's marginal cost of serving one more customer is fractions of a penny. A pharma company's cost scales with every pill manufactured, shipped, and monitored. That single structural difference explains more of the tech-pharma performance gap than any other factor — and it's not the whole story.
May 5
Sector Comparison Report: AI / Technology vs. Pharmaceutical Sectors
Investing in Roche, AstraZeneca, and Eli Lilly captures both the biology wave and the AI productivity wave — without paying the 35x P/E premium of pure-play AI stocks. A dimension-by-dimension comparison of AI/tech vs. pharma, ending in a specific 40-60% allocation recommendation.
Apr 26
bottom of page